Summary. The response of EMT6 mouse tumour cells to ICRF 159, both with and without X-radiation, has been measured during the life of monolayer cultures. The cytotoxic effect of ICRF 159 was found to be proliferation-dependent. Flow cytofluorimetry studies of cell cycle distribution showed that ICRF 159 prevented cell division while allowing DNA synthesis to continue. This anti-mitotic action and the cytotoxic effect of the drug were found to be closely related. Increased sensitivity to X-radiation was observed in cultures pretreated for 24 h with 200 ,ug/ml ICRF 159. In exponential and early plateau cultures this was seen as a reduced shoulder of the survival curve. In late plateau cultures there was no apparent reduction of the shoulder, but an increase in slope.
ICRF 159, ((jA)-1,2,-bis(3,5-dioxopiperazin-1-yl) propane), is a cytotoxic agent which has been shown to kill cells during a brief period of the cell cycle . Using synchronized cultures of human lymphocytes stimulated into division by phytohaemagglutinin, Sharpe, Field and Hellmann (1970) showed that ICRF 159 prevented these cells from entering mitosis. This effect was only found when the cells were exposed to the drug during the premitotic (G2) phase, with little or no effect from exposures to the drug at other phases of the cell cyckb. Similarly, studies on erythroid maturation in C57BL mice indicate that the drug has a similar action in vivo (Blackett and Adams, 1972) . In studies using the spontaneously metastasizing Lewis lung tumour, ICRF 159 has been shown to function as an antimetastatic agent at doses which have little effect on the primary growth (Burrage,  Salsbury, Burrage and Hellmann, 1970) . This action has been attributed to a normalization of tumour vasculature in ICRF 159-treated tumours. This angiometamorphic effect may then prevent dissemination of cells from the primary growth (LeServe and Hellmann 1972; James and Salsbury, 1974; Salsbury, Burrage and Hellmann, 1974) . The antimetastatic effect has not, however, been demonstrated in other spontaneously metastasizing systems (Pimm and Baldwin, 1975) .
Potentiation of X-ray lethality by ICRF 159 has also been observed in experimental tumours (Hellmann and Murkin, 1974; Norpoth et.al., 1974) and also reported in the clinical situation (Ryall et al., 1974) . It has been suggested that this might be due to the improved blood supply resulting from the angiometamorphic effect, with a consequent rise in oxygen tension in the tumour tissue and increased radiosensitivity (Norpoth et al., 1974) .
Should X-ray potentiation by ICRF 159 be due solely to the improved tumour vasculature, rather than a direct effect on the tumour cells, then no such potentiation should occur in monolayer cell cultures growing in vitro. It was to clarify this point that the following work was undertaken.
METHODS

Cell line
The cells used in this study were EMT6/ M/CC. Cells were cultured in 30-ml plastic flasks (NUNC (UK) Ltd) containing 5 ml of Eagle's MEM supplemented with 20% calf serum and gassed with a mixture of 95% air and 5% CO2. Full culture details have been reported previously from our laboratory (Twentyman et al., 1975) .
Cell kinetics
The proliferation kinetics of this cell line have been described fully (Twentyman et al., 1975 
Survival assay
Immediately after irradiation or ICRF 159 treatment, the cells were removed from the surface of the flask by 15 min incubation with 0.075% trypsin solution. Two washes were used to ensure adequate removal of the drug. Following resuspension in medium, the cells were counted in a haemocytometer. After the appropriate dilutions, the cells were plated into 50-mm plastic culture dishes (Sterilin). These were incubated at 37°C for 10 days in plastic boxes gassed with 95% air and 5% C02 and at high humidity. Survival was determined at the end of this time by fixing and staining, and counting colonies containing 50 or more cells.
Flow cytofluorimetry (FCF)
The method of staining cell nuclei for this technique has been fully described by Krishan (1975) .
Briefly, the cells to be analysed were removed from the flasks by trypsinization, resuspended in medium and then spun down at 200 g for 5 min. The resulting cell pellet was resuspended in an ice-cold hypotonic Na citrate solution (1 g/l) containing 0-005% propidium iodide, a fluorescent DNA-coupling agent. Lysis of the cells occurs, and 10-15 min was allowed for complete staining of the intact nuclei. Histograms of the nuclear DNA content were then obtained using a Biophysics Model 4800A Cytofluorograf (Shandon Instruments Ltd). 95% confidence limits in parentheses. + ICRF 159 (200 ,ig/ml) for 24 h before X-rays.
* Labelling index (LI) from previous laboratory data.
RESULTS
All points shown in the figures represent a surviving fraction estimated from the mean colony count on 4 replicate dishes. The errors associated with individual determinations were small compared with the spread of results between separate determinations. Where sample errors have been shown, these have been calculated from the Poisson variance as described by Boag (1975) . The errors shown in the Table are for the aggregated results and are calculated from the regression analysis.
(i) Dose response ( Fig. 1) The surviving fraction of exponentially growing cells falls rapidly as the concentration of ICRF 159 is increased to a threshold level of about 1 ,ag/ml. Thereafter a plateau is reached, with no further change in surviving fraction at concentrations up to 10 ,ug/ml. At higher concentrations a significant increase (P < 0-01) in surviving fraction is observed, from 0-08 at 10 ,ug/ml to 0*20 at 200 ,tg/ml, where once again a plateau is reached. Early and late plateau cultures show a progressively decreasing response to the drug, with surviving fractions of 0-60 and 0'80 respectively after 24 h exposure to 200 ,ug/ml of ICRF 159.
(ii) Time response (Fig. 2 
DISCUSSION
The cytotoxicity of ICRF 159 on EMT6 tumour cells grown in vitro appears to be highly dependent on the proliferating ability of the cultures. Thus, cytotoxicity decreases as the non-proliferating component of the cell culture increases. This cycle specificity has been reported by other workers, both in vivo (Blackett and Adams 1972) and in vitro (Hallowes, West and Hellmann, 1974) using other cell systems.
The manifestations of the cytotoxicity of ICRF 159 on exponentially growing cultures of EMT6 cells would, however, appear to be rather more complex than those observed by other workers using other cell lines. Hellmann and Field (1970) found that exposure of Hep/2 cells to various concentrations of ICRF 159 caused a nearly linear fall in cell survival, approaching zero at drug-exposure times equivalent to one cell cycle. It was concluded that cells were, therefore, being killed as they passed through that part of the cycle sensitive to ICRF 159. The small deviation from linearity of the curve was accounted for by the presence of a small number of more slowly dividing cells. Using EMT6 cells, an exponential decrease in survival is also observed for drug exposures up to 12-14 h (about 1 cell cycle time). However, at this time the surviving fraction is still relatively large (,0.30). Even after drug exposure times of 24 h the surviving fraction is 0-20. There is also a considerable deviation from the initial exponential decline at drug-exposure times greater than 12 h. Previous studies on exponential cultures of EMT6 cells (Twentyman et al., 1975) have indicated that all cells are in cycle, with very few cells with cycle times in excess of 12-14 h.
There are two probable explanations for this deviation of the curve. Firstly, we could be dealing with a heterogenous cell population, with respect to ICRF 159 sensitivity. More sensitive cells would be killed rapidly with early exposure to the drug, thus leaving a more resistant population. Alternatively, the concentration of ICRF 159 used could increase the time taken for cells to reach a sensitive phase of the cell cycle. The latter proposal seems more likely, in view of the response of exponential cultures to various ICRF 159 concentrations for 24 h (Fig. 1) . Relatively low concentrations of ICRF 159 (5-10 ,ug/ml) have a more lethal effect than much higher concentrations (200,ug/ml) . This effect has also been reported for BHK-21S cells grown in culture (Stephens, 1974) . FCF analysis of cultures exposed to 10 jtg/ml (Fig. 6 a) The radiation-potentiation effect appears to manifest itself in two distinct ways. In exponential and early plateau cultures the increase in radiation sensitivity appears to be entirely due to a decrease in the width of the shoulder, as shown by decreases in the values of n and Dq. The width of the shoulder of the radiation-response curve is thought to be associated with the cell's ability to accumulate and repair sublethal radiation damage (Elkind and Sutton, 1959) . Preliminary experiments with split doses of radiation appear to confirm that ICRF 159 is substantially reducing this capability. We will be reporting the split-dose radiation results fully in a later communication. With late plateau cells, however, ICRF 159 has little, if any, effect on the shoulder. Instead it causes a small but significant increase in the slope of the curve. It is possible that both effects occur in the exponential and early plateau cultures, but that the large shoulder component of these cultures, much reduced in late plateau cultures, is masking the small changes in the slope.
These results show that ICRF 159 has the ability to potentiate radiation lethality in a system in which the drug's ability to alter tumour vasculature can play no part. The presence of more than one mechanism of potentiation in vitro is possible, as seen from the differences between the exponential and late plateau cultures. This does not exclude the possibility that there may be further mechanisms operating in vivo, such as the angiometamorphic effect.
We are currently investigating the mechanism of ICRF 159 radiopotentiation and the relationships between cell cycle and drug sensitivity, using the EMT6 cell line grown both in vitro and in vivo.
